Clinical efficacy of thalidomide combined with intrapleural injection of interleukin 2 in the treatment of lung cancer with malignant pleural effusion

Objective To explore the safety and clinical effcacy of thalidomide combined with interleukin 2(Ⅱ-2)treatment of lung cancer complicated with malignant pleural effusion(MPE).Methods From March 2013 to March2013,60 cases of lung cancer with MPE were selected and divided into the experimental group and the